Pyrenebutyrate Pt(IV) Complexes with Nanomolar Anticancer Activity

Research on platinum-based anticancer drugs continuously strives to develop new non-classical platinum complexes. Pt(IV) prodrugs are the most promising, and their activation-by-reduction mechanism of action is being explored as a prospect for higher selectivity and efficiency. Herein, we present th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmedova, Anife, Mihaylova, Rositsa, Stoykova, Silviya, Mihaylova, Veronika, Burdzhiev, Nikola, Elincheva, Viktoria, Momekov, Georgi, Momekova, Denitsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537052/
https://www.ncbi.nlm.nih.gov/pubmed/37765279
http://dx.doi.org/10.3390/pharmaceutics15092310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537052/
https://www.ncbi.nlm.nih.gov/pubmed/37765279
http://dx.doi.org/10.3390/pharmaceutics15092310

Ejemplares similares